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Depression is an issue that is close to my heart. Members of my family, myself 
included, have battled depression. Working in the cardiac cath lab at the University of 
Kentucky Medical Center (UKMC) over the past five years has provided great insight 
into the cardiac population. Cardiac patients suffer from depression at a rate higher than 
the general population. I am particularly interested in depression in the heart failure and 
implantable cardioverter defibrillator population (ICD). This patient cohort deserves 
better management of depression by their cardiology teams.  
 In 2012 the American Heart Association (AHA) released a scientific statement 
including recommendations for depression screening and management in the ICD 
population. The statement suggested that more research was needed to determine the best 
method of depression screening for ICD patients. To determine this I turned to the wealth 
of information on depression in the more general population of heart failure. Manuscript 
one is a literature review of depression screening tools used in the heart failure 
population. Based on the evidence available, I have made recommendations for 
depression screening instrument use in the heart failure population.  
 Manuscript two takes somewhat of a left-turn and analyzes current legislation that 
if passed, could impact the psychosocial needs of the heart failure population in the 
United States. Using Kingdon’s Stream Theory, I have unpacked The Patient Centered 
Quality of Care for Life Act (HR 1666) and assessed its potential impact in the heart 
failure community.  
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Manuscript three is the evaluation of my capstone research that has taken place 
over the past six-months. In response to the AHA statement released in 2012, I 
implemented a depression screening protocol specific to the ICD population in a UKMC 
cardiology clinic. Extrapolating from the evidence I found in my literature review of 
depression screening instruments used in heart failure patients, I applied the same 
principles the ICD patient population. Manuscript three reviews the methods and results 
of my work.  
 The overall focus of my capstone is to provide the best evidence to support 
process improvement for evaluating depression in patients with ICDs. Depression cannot 
be ignored in this population and must be addressed by cardiology providers. 
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ABSTRACT 
 
Background: Depression in the heart failure (HF) population has been widely studied and 
found to have profound implications for patients and the health care system. Heart failure 
patients who experience depression are more likely to be nonadherent to medical 
recommendations, and have increased mortality with higher healthcare resource use than 
non-depressed counterparts. Depression identification and treatment are necessary to 
prevent adverse outcomes. Objective:  In this literature review, I analyzed  literature in 
which depression screening instruments were either compared or individually evaluated 
in the heart failure patient population. I objectively determined the best fit for use by 
providers in primary care and inpatient settings. Methods: A review of the literature was 
conducted using CINHAL and PubMed databases. Focus was on research articles 
published within the last ten years that included comparison or analysis of a depression 
screening instruments in HF patients. Key search terms included: depression, heart 
failure, depression screening, and depression screening tools/instruments, depression 
assessment, and depression measurement in heart failure. Eight articles met the inclusion 
criteria and were critiqued by an independent reviewer. Results: Many depression 
screening instruments that are currently being used in the HF population may not be 
ideal. Instruments found to be appropriately used in the HF population include: Hospital 
Anxiety and Depression Scale (sensitivity 100% Specificity 79%), Depression in the 
Medically Ill – 18 (PPV-47.5% NPV-93%), Depression in the Medically Ill – 10(PPV-
40.2% NPV-93%), PHQ-9 (sensitivity 70% specificity 92%), PHQ-2 (sensitivity 90% 
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specificity 69%), PROMIS depression short form (sensitivity 89% specificity 82%), 
Diagnostic Interview Schedule (Sensitivity 80% specificity 84%), and Cardiac 
Depression Scale with a Moken scale analysis of low strength (H<0.40) and high 
reliability (Rho>0.8). Conclusions: Depression screening instruments are chosen based 
on validity and reliability with in a patient cohort, provider preference and ability to be 
used efficiently in the clinical setting. It was found that while categorical depression 
screening tools are more thorough, dimensional tools are more efficient. Additionally 
some dimensional tools were lengthy and may not be ideal for primary care or medical 
inpatient setting due to time constraints. The PHQ-9 was found to be a potential favorite 
with good internal consistency, reliability, and concurrent validity. PHQ-9 contains only 
nine questions and was the second shortest screening tool evaluated. 
Key Words: depression, heart failure, depression screening tools, depression screening, 
depression screening tools/instruments, depression assessment, and depression 
measurement in heart failure. 
 
INTRODUCTION 
 
 According to the American Heart Association (AHA), “heart failure (HF) is a 
chronic, progressive condition in which the heart muscle is unable to pump enough blood 
through to meet the body’s needs for blood and oxygen.” 1According to the AHA 2014 
Heart Disease and Stroke Statistics, approximately 5.1 million adult Americans have a 
diagnosis of HF.2 This number is projected to increase to 8 million by 2030.2 In 2010 HF 
was the chief complaint of approximately 1,801,000 physician office visits, 676,000 
emergency room visits, and 236,000 out-patient visits.2 This translates into enormous 
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healthcare costs. In 2012 the diagnosis of HF was estimated to cost $30.7 million dollars 
with a projected increase of over 125% or 69.7 billion dollars by the year 2030.2 Heart 
failure causes increased morbidity and mortality, increased medical costs, and a 
significant decrease in quality of life.3 Depression in this population further potentiates 
these complications. Independently, depression is estimated to cost over 83 billion 
medical and work place dollars per year.3 Efforts are needed to identify depression in the 
HF population and to improve long-term outcomes. Many depression screening 
instruments are available to the provider; however, it is unclear which instruments are 
best used in specific settings. The purpose of this review is to analyze the literature in 
which depression screening instruments are either compared or individually evaluated in 
the HF population and to provide recommendations for use by HF providers.  
BACKGROUND AND SIGNIFICANCE 
 HF is a pathophysiologic condition that is defined by a reduction of cardiac 
function.4   This physiologic alteration results in the heart’s inability to efficiently pump 
blood at a rate that meets the metabolic needs of the body. This affects the body’s 
homeostasis and disrupts many organ functions.  Four characteristics of HF that decrease 
quality of life include neurohormonal activation, decreased heart rate variability (HRV)/ 
rhythm disturbances, inflammation (cytokine release), and impaired platelet function.3  
Patients with HF have a higher prevalence of depression than individuals with other 
medical conditions.5 Medically ill patients with depression have a reduction of adherence 
to directed therapy, as well as 50%-100% higher medical costs than their non-depressed 
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counterparts.5 A reduction in depressive symptoms in HF and other medically ill patients 
improves adherence to therapy and decreases costs.5,6 Patients with comorbid HF and 
depression must be identified and treated in order to reduce the financial and quality of 
life disparities within this population.  
LITERATURE REVIEW 
 This review of the literature targeted research in which depression screening 
instruments are either compared or individually evaluated in the HF population. The 
English language PubMed and CINAHL databases were searched using search terms: 
depression, heart failure, depression screening tools, depression screening, depression 
screening tools/instruments, depression assessment, and depression measurement in heart 
failure. 
 Inclusion criteria for articles were as follows: published within the last 10 years, English 
language, full-text and include either a comparison or evaluation of a depression 
screening instrument used in the HF population. Studies included were randomized 
controlled trials, meta- analyses, literature reviews, and secondary analysis of randomized 
controlled trials that involved comparison or evaluation of depression screening 
instruments used in the HF population. Searching with these criteria produced 222 
studies, the majority of which did not meet the inclusion criteria, leaving only 8 studies to 
be focused on for this literature review.  
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Characteristics of Instruments 
 According to the American Psychiatric Association (APA), a diagnosis of major 
depression is based on the identification of at least one of two core symptoms (A 
symptoms) with at least four or more secondary symptoms (B symptoms) for a total of 
five symptoms.7 Minor depression is diagnosed in much the same way as major 
depression but with fewer than five total symptoms, one of which must be an A 
symptom.7 In both depression categories, symptoms must be present for at least two 
weeks. Both A and B symptoms can be seen in Table 1 in the appendix section.7 
Depression screening instruments must be able to identify depressive symptomatology in 
the HF patient.  
 Screening instruments are broken down into two categories: Categoric or 
diagnostic interview screening instruments and dimensional or self-reporting instruments. 
Categoric depression screening instruments are used by a systematically trained 
interviewer; however, dimensional instruments are based upon self-reporting and ranking 
of symptom severity by the patient.8 Categoric instruments can be used to diagnose 
depression, as they are utilized by trained professionals.8 Dimensional instruments are 
designed to detect depressive symptoms that are reflective of a likely depression 
diagnosis.8  In this literature review, 1 out of 8 studies examined the use of categorical 
instruments.9  Dimensional instruments were discussed in 5 out of 8 studies.3,10-13 
Dimensional and categoric instruments were evaluated in 2 out of 8 studies.8,14 (see table 
2 in appendix) Categoric instruments were found by one study  to be more reliable in 
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detecting depression in HF that was previously not found by use of dimensional 
instruments.8 However, dimensional instruments were found to detect the highest rates of 
depressive symptoms.8 Categoric instruments depend on the accuracy of the interviewer 
for reliability.8 Dimensional instruments depend on the forthcoming of the self-reporting 
patient.8  
Appropriate Use 
 Several studies found in this review spoke to the overlap of symptoms between 
depression and HF.3,8,9,14 Fatigue, weight changes, and poor concentration are just a few 
examples of symptoms that can be attributed to both depression and HF. Depression 
screening instruments used in this population will offer the most benefit when they are 
able to distinguish true depressive symptoms from physiologic changes occurring in the 
HF patient. Despite their extensive validity and reliability, several dimensional 
instruments are unfavorable in the HF population due to the inability of the instrument to 
account for symptom overlapping. These instruments include the Beck Depression 
Inventory (BDI), the Geriatric Depression Scale (GDS), the Center for Epidemiologic 
Studies-Depression Index (CES-D), the Hospital Anxiety and Depression Index, the 
Medical Outcome Survey-Depression Instrument, and the Zung depression Scale.  
Conversely, recent research by Lee et al. found that depression screening 
instruments that include physical depressive symptoms to assess depression in HF 
patients do not necessarily falsely represent the relationship of depressive symptoms to 
cardiac even-free survival.15 This means that use of depression screening tools that 
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include physical depressive symptoms can be used with confidence that the outcomes are 
accurate despite the presence of both affective and physical symptoms.15 Clearly there is 
much debate within the literature.  
Ease of use  
 Choosing a depression screening instrument is based on validity and reliability 
within a patient population, as well as the adaptability of the instrument for use. The 
categorical instruments (Cardiac Depression Scale & Diagnostic Interview Schedule), 
although accurate and able to diagnose depression, may not be the best choice for 
primary care providers as they are lengthy and require accuracy on the part of the 
interviewer.8,9 This process can be time consuming for both patient and provider.  
 Dimensional instruments are certainly more convenient to the provider as they are 
primarily in patient self-reporting style.8 Dimensional instruments such as the Patient 
Health Questionnaire (PHQ-9), the Patient Health Questionnaire (PHQ-2), the Hospital 
Anxiety and Depression Scale (HADS), and Depression in the Medically Ill (DMI-18/10) 
can range from 2-18 items per evaluation.3, 11,12,13 Lengthier screenings may take more 
time for some patient populations depending on their reading and cognitive function. 
Dimensional instruments were also found by one systematic review to have higher 
frequencies of depression symptoms (21-60%) than categoric instruments (14-39%).14 
Convenience and higher frequencies of detection of depression symptoms are convincing 
qualities of this style of instrument.   Interestingly, one recent study compared the 
methodology of administering dimensional tools (PHQ-9, HADS, and PROMIS- 
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depression short form 8a) in standard form versus individual-tailored computer-adaptive 
testing (CAT).12 The research found that the diagnostic capability of these instruments 
were similar regardless of the administration method.12 CAT had an advantage over 
traditional implementation in that it could be individually tailored to the respondent and 
therefore decrease the burden for some patients with differing mental capabilities.12 
IMPLEMENTATION OF INSTRUMENTS 
 The studies analyzed in this review have been successfully implemented in a 
variety of settings in which they are being used to predict health behaviors and mortality 
rates. In a study by Bauer et al.6, the PHQ-9 and HADS instruments were utilized to 
determine if improvement in depression also improved adherence to medical therapy in a 
group of cardiac patients.6 The study looked at depression six months after hospitalization 
and found that improvement in depression symptoms appeared to improve compliance 
rates among cardiac patients.6 A second study by Sherwood et al.4 found that a BDI score 
of >10 to determine a hazard ratio of 1.56 (95% confidence interval) for the combination 
of death or hospitalization related to a cardiovascular event within a HF patient cohort.4  
The Heart Failure Adherence and Retention Trial (HART) was a behavioral trial that 
examined patient self-management and HF education as a means to improve patient 
outcomes.16 This trial used the GDS with a cutoff point of >10 as a measure for 
depressive symptoms. HART found that patients who scored >10 on the GDS had 
significantly more hospitalizations per year than did the patients who scored <10.16 The 
study concluded that depression was a major predictor of non-compliance to medical 
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therapy as well as hospital readmission. The study recommended that depression be 
identified as soon as possible in the HF patient.  
Results 
 Many depression-screening instruments have been found to be valid and reliable 
in many patient populations. Identifying depression in the HF cohort can be a challenge 
for the provider, as many depressive and physical symptoms overlap. Choosing the best 
instrument for use in the population depends on the setting of the patient and provider. 
Instruments found to be reliable by this review in the HF patient included HADS 
with100% sensitivity and 79% specificity when cutoff score for depression was 8, 93% 
sensitivity and 85% specificity with a cutoff of 7, and 86% sensitivity and 79% 
specificity with a cutoff of 4.3,11 Depression in the Medically Ill -18 (DMI-18) with a  
cut off of >14 showed a positive predictive value (PPV) of 47.5% and a negative 
predictive value (NPV) of 93.0%.13 Depression in the Medically Ill -10 (DMI-10) 
which was most beneficial with a cut off of >6, had a PPV of 40.2% and NPV of 
93.1%.13 PHQ-9 was found to have a sensitivity 54% and specificity 90% when cutoff 
>10 by Smith, however, Hammash et al. found the PHQ-9 to have a sensitivity of 70% 
and specificity of 92% when the cutoff was 10.3,10 Patient Health Questionnaire-2 
(PHQ-2) was found reliable with a sensitivity 90%, and specificity 69%.3 PROMIS-
Depression short form was also found to be reliable in this population with a sensitivity 
of 89% and specificity of 82% when the sum core was 9.5.12 Categoric tools found to be 
appropriate for use in the HF population were the Diagnostic Interview Schedule (DIS) 
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with a sensitivity of 80% and a specificity of 84% and the Cardiac Depression Scale 
(CDS) with a Mokken scale analysis of low strength (H<0.40) and high reliability 
(Rho>0.8).9,14 Despite a negative review by Smith, the BDI and GDS were found by 
others to be reliable depression screening instruments, and in some cases, the gold 
standard for depression screening, however, the issue of potential symptom overlapping 
and length of instrument prevented theses instruments from being recommended by this 
review. 3,8,10,11  
Categoric instruments that utilize interview techniques by a trained professional 
may be too lengthy for the HF provider in both the clinic and hospital settings. However, 
these instruments may be useful for further investigation once depressive symptoms have 
been identified.  
Dimensional instruments are a good option for depression screening by the HF 
provider both in clinic and in-patient settings and offer an array of choices for the 
provider. The literature seems to be conflicted as to which dimensional instruments are 
best for use in HF patients. For example, the HART study found that the GDS may not 
have been the best option in that study based on a sensitivity of 56.3% and a specificity of 
73.6%.16 Other instruments, such as the BDI, HADI, and CES-D, contain 14-20 items per 
inventory. While found to be sound choices by many researchers, these instruments may 
prove too difficult and lengthy in some populations. Patients who are elderly or have 
difficulty reading may have challenges completing assessments such as these.   
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 The HART study also suggested that the PHQ-2 may be the most useful 
instrument as it only contains two questions which can be administered into routine 
patient encounters.16 The PHQ-9 should be considered applicable in this patient 
population as it contains nine items. Hammash et al. found that the PHQ-9 was a 
consistent and reliable depression screening instrument and supported its consistency 
when compared to the BDI as the gold-standard.10 The BDI has long been used for 
depression screening in many patient populations; the PHQ-9 has now been determined 
to be equivocal. The nine-item self-reported screening may be the best combination of 
known depression screening methods for HF patients due to its confirmed vality and 
reliability and its versatile use as either a categoric or dimensional tool.3,8,10,12 Recent 
research has also verified that the PHQ-9 can be used in HF patients with out worry of 
overestimation of depressive symptoms and outcomes.15 
Discussion  
Recommendations for inpatient HF depression screening methods are 
extrapolated from the literature and evaluated based on validity and reliability and ease of 
use for patient and provider. In order to create a streamlined approach, the PHQ-2 can be 
used for every in/out patient encounter. The two item screening can provide evidence 
based direction for providers. If the screening is positive, the provider can administer the 
PHQ-9 either by interview or self-reporting method, for further delineation of depressive 
symptoms.3,10,12 Treatment can then be directed based on the severity of the depressive 
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symptoms. Other categoric interview instruments may be of use once the initial screening 
has occurred and depression has been identified.  
In a clinic setting, the PHQ-9 may be given to the patient for self-reporting while 
he or she is filling out other pertinent forms. The 9-item inventory will take less time than 
many of the other self-reporting instruments. The patient can present the form to the 
physician during the office visit for further review. In this setting, the PHQ-2 followed by 
administration of the PHQ-9 may take additional time that could be saved by the patient 
self reporting on only one instrument and presenting it for review. The provider can 
quickly look at the form and determine if there is a need for further investigation based 
on a cutoff score of 10 or greater. The PHQ-9 can also be given in an interview format by 
the provider, which may increase accuracy and consistent use of the instrument. The 
PHQ-9 has published recommended treatments depending on score and severity of 
depression.17 This algorithm would be most useful for providers if easily accessible. This 
methodology will vary among providers and settings.  
CONCLUSION 
It is clear that many depression-screening instruments are available for use in the 
HF population. Many instruments have been reviewed and validated in the literature. No 
one instrument can be said to be the best or single standard for any and every situation. It 
may be best to take each provider and each patient into consideration when deciding on a  
depression screening instrument. The most vital recommendation made from this review  
is that standardized screening for depression in HF patients is a necessity for the benefit  
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of both the patient and the health care community. The PHQ-9 alone or preceded by the  
PHQ-2 is a reasonable option and is supported by the literature for use in the HF  
population. 
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WHAT’S NEW?  
 
• Not all depression-screening instruments are equal within the heart failure 
population and setting must be considered when choosing a depression-screening 
instrument. 
• PHQ-9 may be a reasonable choice for primary care and inpatient settings as it is 
a brief 9-item survey that can be implemented by the provider or delivered to the 
patient for self-reporting.   
 
 
Table 1: Symptoms and Severity of Major Depression According to the American 
Psychiatric Association14 
 
Symptom Group 
A symptoms:  - Depressed, sad mood most of the day 
- Markedly diminished interest or pleasure in all or almost all 
activities most of the day, nearly every day 
 
B symptoms: - Weight loss or weight gain, or decreased or increase in appetite 
- Insomnia or hypersomnia 
- Psychomotor agitation/retardation 
- Fatigue or loss of energy 
- Feeling of worthlessness or inappropriate guilt 
- Diminished ability to think or concentrate or ambivalence 
- Thoughts of death or suicidal ideation 
Severity 
Mild: - At least one A and four B, ability to function normally but with 
substantial and unusual effort 
Moderate: - A severity between mild and severe 
Severe - Presence of most symptoms and observable disability (affection 
work or childcare) 
 
Table 2: Depression screening instruments discussed in this review: 
 
 
Tool 
 
Studies 
 
Description 
 
Recommendation 
DIS Johansson et al. (2006) Categoric – Provider 
interview 
Best used by psychiatric 
services or as follow up 
to positive screening tool. 
CDS Ski et al. (2012) Categoric – Provider 
interview 
Used only in HF 
populations and as follow 
up to positive screening. 
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BDI Hammash et al. (2013), 
Johansson et al. (2006), 
Delville et al. (2008) 
Dimensional – Patient 
self-reporting 
Can be used for primary 
care or inpatient and as a 
single tool or as follow up 
to positive screening. Use 
with caution, may not 
account for symptom 
overlapping in HF 
patients.  
PHQ-9 Hammash et al. (2013), 
Smith (2010) Fischer et 
al. (2013) 
Johansson et al. (2006) 
 
Dimensional – Patient 
self-reporting 
 
Categoric – Provider 
interview 
Can be used for primary 
care or inpatient and as a 
single tool or as a follow 
up to positive screening.  
GDS Johansson et al. (2006), 
Delville et al. (2008), 
Haworth et al. (2007),  
Dimensional – Patient 
self- reporting  
Can be used for primary 
care or inpatient. Comes 
in a 30 and 15 item 
formats. Can be used as a 
single tool or as follow up 
to positive screening. Use 
with caution, may not 
account for symptom 
overlapping in HF 
patients. 
HADS Johansson et al. (2006), 
Haworth et al. (2007), 
Smith (2010) Fischer et 
al. (2013) 
Dimensional – Patient 
self – reporting  
Can be used for primary 
care or inpatient. 
Requires a reduced cut 
off point of 8 in the HF 
population.  
CES-D Smith (2010), 
Johansson et al. (2006), 
Delville et al. (2008) 
Dimensional – Patient 
self-reporting 
Was not found to be 
favorable in the HF 
population due to 
symptom overlapping. 
Hospital Anxiety and 
Depression Index 
Smith (2010), Delville 
et al. (2008) 
Dimensional- Patient 
self-reporting 
Was not found to be 
favorable in the HF 
population due to 
symptom overlapping. 
Medical Outcome 
Survey-Depression 
Instrument 
Smith (2010), 
Johansson et al. (2006), 
Delville et al. (2008) 
Dimensional – Patient 
self-reporting 
Was not found to be 
favorable in the HF 
population due to 
symptom overlapping. 
Zung Depression Scale Smith (2010), 
Johansson et al. (2006), 
Delville et al. (2008) 
Dimensional – Patient 
self-reporting 
Conflicting evidence 
regarding usefulness in 
HF population. Use with 
caution as it may not 
account for symptom 
overlapping.  
DMI-10/18 Smith (2010) 
Hilton et al. (2006) 
Dimensional – Patient 
self-reporting 
10 and 18 item format 
may be used in primary 
care and inpatient care. 
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Found to account for 
symptom overlapping by 
exclusion of somatic 
items. 
PHQ-2 Smith (2010) Dimensional – Patient 
self-reporting 
2 item inventory in yes/no 
format. Found useful in 
primary care and 
inpatient care as 
screening only. Must be 
followed up by diagnostic 
tool.  
PROMIS- Depression 
Short Form 
Fischer et al. (2013) Dimensional- Patient 
self-reporting 
8 item likert scale that 
can be completed and 
scored via hard copy 
method or Computer 
Adaptive Test (CAT). 
Useful in primary care 
and inpatient care 
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The Patient Centered Quality Care for Life Act and Heart Failure 
Statement of the problem:  
  Seriously ill patients with chronic health conditions and their caregivers have 
complex needs that our health care system is ill prepared to meet. Independent of new 
healthcare policy and expenditures, a patient-centered approach to care can improve 
patient and care giver outcomes (Dudas et al., 2012;Meier, 2011; Mirzaei et al., 2013). 
The Institute of Medicine (IOM) defines patient-centered care as “Health care that 
establishes a partnership among practitioners, patients, and their families (when 
appropriate) to ensure that decisions respect patients' wants, needs, and preferences and 
that patients have the education and support they need to make decisions and participate 
in their own care”(IOM, 2001). 
In April of 2013, the Patient Centered Quality Care for Life Act (House of 
Representatives, HR 1666) was introduced to the House of Representatives by 
Representative Emanuel Cleaver of Missouri. This piece of legislation was supported by 
47 cosponsors and has been referred to the subcommittee on health. HR 1666 has many 
components and legislative directives that would support patient-centered care efforts for 
many patient cohorts. The following items are included in HR 1666 and would become 
law upon this bill being passed by both the House and Senate:  
• Formation of a stakeholder strategic summit via the Department of Health 
and Human Services (DHHS) to analyze barriers and solutions to patient-
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centered care in chronic illness. Participants of the summit would include 
Federal and private organizations.  
• Amendments to the Public Health Service Act, which would require the 
Centers for Disease Control and Prevention (CDCP) to provide grants for 
education and awareness of palliative care for seriously ill patients, 
families, and health care professionals. 
• Direction of the Health Resources and Services Administration (HRSA) to 
provide medical professional workforce training to promote patient-
centered care of seriously ill patients with chronic diseases.  
• Update to the 2002 HRSA report, “The Supply, Demand and Use of 
Palliative Care Physicians in the United States.”  
• Establishment of a Quality of Life Advisory Committee to assist the 
CDCP and HRSA to conduct quality of life education and awareness 
dissemination for cross agency implementation. 
• Expand national research programs, via the National Institutes of Health 
(NIH), regarding symptom management, palliative, psychosocial, and 
survivorship care.  
Background and significance of the issue: 
Patient-centered care has been studied in many patient populations and is an 
effective approach to improving outcomes in those with chronic illnesses (Meier, 2011; 
Mirzaei et al., 2013; Poochikian-Sarkissian, Sidani, Ferguson-Pare, & Doran, 2010). 
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More specifically, the patient-centered approach is associated with improved patient 
outcomes in the heart failure population (Dudas et al., 2012). According to the American 
Heart Association (AHA), “heart failure (HF) is a chronic, progressive condition in which 
the heart muscle is unable to pump enough blood through to meet the body’s needs for 
blood and oxygen”(American Heart Association [AHA], 2012). According to the Center 
for Disease Control (CDCP), approximately 5.7 million Americans are currently living 
with chronic heart failure (CDCP, 2013). Half of these Americans will die within 5 years 
of being diagnosed (CDCP, 2013).  
The AHA recently released a Scientific Statement entitled “Decision Making in 
Advanced Heart Failure” (Allen et al., 2012). This statement introduces the concept of 
shared decision making between clinicians and heart failure patients, which follows the 
principle of patient-centered care as defined by the IOM (Allen et al., 2012, p. 1929). The 
Affordable Care Act also addresses patient-centered care, devoting 4 pages to shared 
decision-making and collaboration of care initiatives (Allen et al., 2012).  
Quality of life issues such as uncertainty and depression are common in the heart 
failure population and further potentiate medical complications (Dudas et al, 2012). 
Patients with heart failure who have depressive symptoms have increased morbidity of up 
to 4 times the national average (Moraska et al., 2013). Heart failure patients have a higher 
prevalence of depression than other medical populations (Moraska et al., 2013;Taylor et 
al., 2008).  Depression rates in heart failure patients are consistently higher than in the 
general population and are thought to range from 5-10% (Moraska et al., 2013). Research 
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has demonstrated that a reduction in depressive symptoms in heart failure and medically 
ill patients improves adherence to therapy and decreases medical costs (Taylor et al., 
2008; Bauer et al., 2012). It is estimated that heart failure costs are approximately $34.4 
billion US dollars each year, which includes the cost of health care services, medications, 
and lost productivity (CDCP, 2013). Adherence to medical therapy is necessary to 
improve quality of life and reduce additional medical costs. A recent study by Bauer et al. 
(2012) found that a reduction of depression in cardiac patients resulted in increased 
adherence to medical therapy over a 6-month period of time. A patient centered approach 
that includes psychosocial interventions is needed in order order to reduce health care 
costs and increase quality of life among the heart failure population.  
   
 The items covered in HR1666 would benefit the heart failure population and other 
patient cohorts by mandating that a patient-centered approach become a regulated model 
in more healthcare outlets. It would also provide channels for grant money to be funneled 
into patient-centered education for medical providers and family. Additionally, HR 1666 
would open up the channels for further research by the NIH into palliative care and 
psychosocial interventions that would best serve heart failure patients as well as other 
chronically ill individuals (H.R. 1666, 2013).  
Conceptual Framework and Analysis of the Issue: 
 To analyze the many political and policy intricacies surrounding this issue and the 
implementation of HR 1666, John Kingdon’s Streams Theory was utilized (Kingdon, 
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2011). This theory focuses on problems, policy, and politics and how they converge to 
impact public agenda and legislation. The problem stream focuses on why the issue is of 
importance and what is currently being done about the issue. The policy stream looks at 
ideas about the issue and ways of correcting the problem such as legislation or non-
judicial measures and alternatives. The political stream focuses on the current political 
climate and what other current political issues could possibly advance legislation or 
constrain it. Kingdon’s theory suggests that when the right policy window is open and 
problems, policy, and political climate are all in alignment, issues become more visible 
on the national or local legislative agendas (Kingdon, 2011). This theory doesn’t forecast 
that an issue or policy will become law but it does provide a modal of how legislation and 
political issues are brought into the public eye and the political agenda.  
The Problem Stream 
 Chronic illnesses such as heart failure are common diagnosis in most healthcare 
institutions. Heart failure alone represents over $34 million healthcare dollars annually 
(CDCP, 2013). Individuals with illnesses such as cancer, respiratory disease, kidney and 
liver failure have high healthcare utilization needs and would benefit from a patient-
centered care approach. Currently there is a need for public involvement and education 
regarding patient-centered care for seriously ill patients and families.  According to HR 
1666, awareness and demand for symptom management that coincides with medical 
treatment would improve the quality of life for patients and their loved ones (H.R. 1666, 
2013).  
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In accordance with a patient-centered approach, utilization of collaborative 
palliative care is also appropriate for seriously and chronically ill patients at any stage of 
illness and should be better implemented in today’s healthcare models. In a recent pilot 
study, patients with heart failure who were recipients of palliative care were found to 
have better perceived control and a reduction in symptom distress (Evangelista, 2014). 
Early palliative care was also found to improve quality of life and mood when offered to 
patients with metastatic non-small-cell lung cancer (Temel et al., 2010). Palliative care is 
one way of providing a patient-centered approach to the seriously and chronically ill and 
is supported by the legislation in HR 1666.  
The Patient Centered Quality of Care for Life Act proposes that less than one 
third of cancer patients and survivors collaborated with by their doctors regarding their 
own quality of life (H.R. 1666, 2013). A 2002 report commissioned by HRSA projected 
that the United States would be lacking palliative specialist and recommended increased 
education and training across all medical specialties that serve seriously ill patients 
(Cohen & Salsberg, 2002; Lupu, 2010). This warning has not been heeded and palliative 
medicine and collaboration continue to be at a loss in most healthcare outlets. Several 
IOM reports regarding palliative care, survivorship, psychosocial care, and pain 
management have also called for increased training in symptom management and 
collaboration of care among patients, families, and caregivers (IOM, 
2001,2006,2007,2011). Again, these reports have not been sufficient to induce the 
paradigm change required to improve seriously ill patient’s satisfaction with their care.  
	  
	  
	  
29	  
	  
	  
	  
Key Stakeholders: One of the primary components to HR 1666 would be to convene a 
patient-centered health care and quality of life stakeholder strategic summit to evaluate 
barriers to patient-centered health care as well as identify solutions to improve quality of 
life among seriously ill patients in the current healthcare environment. The primary 
stakeholders in HR 1666 include DHHS, CDCP, HRSA, and NIH. The adoption of HR 
1666 would directly impact these organizations and require changes to policy and the 
appropriation of funds. Federal agencies such as the Agency for Healthcare Research and 
Quality the Centers for Medicare and Medicaid Services, Department of Veterans 
Affairs, and the Department of Defense would also be included in the stakeholder 
summit. Private organizations such as health insurance organizations, non-profit 
organizations, and faith community representatives would be asked to the summit as well.  
Other key stakeholders in HR1666 would be organizations that are currently supportive 
of the bill. These organizations include:  
Supporting Organizations of HR 1666 
American Cancer Society Cancer Action Network American Academy of Hospice and Palliative 
Medicine 
American Academy of Pain Management American Childhood Cancer Organization 
American Osteopathic Association American Society for Pain Management Nursing 
American Society of Clinical Oncology Association of Oncology Social work 
Cancer Support Community C-Change 
Center to Advance Palliative Care Hospice and Palliative Nurses Association  
LIVESTRONG Foundation National Alliance for Caregiving 
National Association of Social Workers National Coalition for Cancer Research 
National Coalition for Cancer Survivorship National Comprehensive Cancer Network 
National Palliative Care Research Center Oncology Nursing Society 
Society for Social Work Leadership in Health Care Supportive Care Coalition 
The Catholic Health Association of the United 
States 
([HR 1666 Supporters], 2013) 
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The organizations listed in this section have direct impact on the care of seriously ill 
individuals and have the ability to change the status quo of our current healthcare system. 
It is clear that there is a problem with the way chronic and seriously ill patients are 
managed in today’s healthcare model. Changes must be made not only for financial 
reasons, but also to improve the lives of such a large population of Americans.  
The Policy Stream 
 The policy stream surrounding HR 1666 is tumultuous with the Affordable Care 
Act being implemented and its impact on the health care delivery system.  Interestingly 
enough, in 2012, Representative Emanuel Cleaver tried to introduce The Patient Centered 
Quality Care for Life Act under the 112th congress. It was also referred to the 
subcommittee on health where the legislation died. This is potentially the course for the 
current version of the bill despite a lack of opposition to the initiatives and overwhelming 
support of many special interest groups. Timing is everything and currently too many 
current policy changes seem to overshadow the potential adoption of HR 1666. 
Alternatives: For years organizations that support palliative and psychosocial care 
measures have shown the benefit of patient centered care for our seriously and 
chronically ill patient populations. Patient navigators and psychosocial support in these 
patient populations is often talked about; however, little has been done formally to 
change the way these services are delivered. It seems that unless national legislation is 
made that forces the regulatory healthcare bodies to change their approach; little can be 
expected in the way of organized change. It is clear that simply letting the body of 
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literature speak for its self will not be enough for the seriously ill persons who are in need 
of patient centered care now.  
 The Affordable Care Act (ACA) has many components and calls for many 
changes to current health care models. The ACA calls for an increase in quality of care 
and for healthcare agencies to be reimbursed based on quality measures (H.R. 3590, 
2011). The hope is that healthcare outcomes will be evaluated against the quality of care 
provided. Reimbursement will be based on the value of the quality of care. These 
standards will force healthcare agencies to look at evidenced based methods of providing 
quality care. Patient centered care will be necessary when quality and values are driving 
the decisions on how healthcare expenditures are made. Education and research will be 
needed to provide a patient centered approach and to offer palliative care and 
psychosocial services. This may potentially lay the way for HR 1666 to be enacted into 
law which will help unify the organizations such as DHHS, CDCP, HRSA, and NIH 
under one umbrella of patient centered implementation.  
The Political Stream 
Political factors: The Patient Centered Quality of Care for Life Act is a bipartisan bill. 
There are 10 republican and 57 democrat cosponsors (H.R. 1666, 2013). There is no 
political opposition to this piece of legislation; however, it has not ben widely publicized. 
It is currently under review by the House Subcommittee on Health. The current economic 
situation regarding healthcare may constrain action of this legislation. There seems to be 
a substantial amount of uncertainty in the current political environment regarding the 
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launch of the ACA. Part of HR 1666 is to require grant money to be provided by the 
CDCP for education regarding palliative care for families and healthcare professionals. 
HR 1666 also calls for the establishment of a quality of life advisory committee to assist 
the CDCP and HRSA as well as expanded research programs through the NIH. These 
initiatives will cost these organizations funds that may not be available as we launch 
National healthcare reform. The political climate is not currently ripe for this kind of 
health care initiative to be launched. However, as we see changes made to reimbursement 
policy and quality of care become more and more pressing, the right political time for HR 
1666 may be soon at hand. According to Kingdon’s stream theory, the political window 
of opportunity must be perfectly ready for the problems, policy, and the politics to line up 
in such as way that the primary issue takes center stage (2011). This alignment is not 
quite ready but is soon to come. When The Patient Centered Quality Care for Life Act 
was introduced in 2012, it only had 27 cosponsors. The 2013 version had 67 cosponsors 
and numerous special interest groups supporting it. The political time has changed 
drastically since the first attempt at passing this bill and will continue to change over the 
next several years. Legislation that would force regulatory agencies such as DHHS, 
CDCP, HRSA, and NIH to seriously implement patient centered care strategies would 
make a tremendous difference on conditions such as heart failure and other chronic 
illnesses that are known as high healthcare dollar diagnosis.  
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Policy Options:  
 The evidence regarding the heart failure patient population is clear, patient 
centered care that includes psychosocial support, palliative care, and shared decision-
making is best practice (Allen et al., 2012; Moraska et al., 2013). This is applicable in 
multiple patient cohorts as evidenced by the IOM’s Crossing the Quality Chasm’s 
definition of patient-centeredness as “providing care that is respectful and responsive to 
individual patient preferences, needs, and values and ensuring that patient values guide 
all clinical decisions” (Committee on Quality of Health care in America and IOM, 2001). 
Many aspects of health care are leaning toward a patient-centered approach such as the 
advent of the electronic health records that offer access to patient health information as 
well as consumer reports that disseminate medical information to patients and families 
(Mann, 2013). Even the Food and Drug Administration has adopted a new program 
called Patient-Focused Drug Development, which collaborates with patients in specific 
disease populations (Mann, 2013, p. 1). 
 It seems there are only two options for the Patient Centered Quality Care for Life 
Act. First option is to adopt the legislation and have an organized approach to 
implementation of patient-centered care into already established healthcare organizations. 
Second option is to let the legislation die and allow the growing body of literature and 
other organizations individually develop varying interpretations of what this concept 
means and how it will function from one healthcare outlet to the next.  
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 The Commonwealth Fund believes that the adoption of improvement models for 
improving care at the end of life will take more than just the creation of innovative 
programs (Hostetter & Klein, 2012). Improvements to patient-centered care that includes 
palliative care implementation and end of life care will take organized education and 
collaborative learning approaches (Hostetter & Klein, 2012). Perhaps passing legislation 
and the concepts proposed in HR 1666 will provide the structure and processes needed to 
implement patient-centered care models appropriate to the growing population of 
chronically and seriously ill.  
Best Policy Conclusions: 
Implementation of evidence-based practice should not require national legislation. 
However, many healthcare systems may not be as motivated for issues such as palliative 
care and symptom management when compared to new innovative treatments that 
promise high reimbursement rates. Healthcare is changing and part of this reform may 
include a shift to value-based reimbursement (Agency for Healthcare Research and 
Quality [AHRQ], 2013). This shift will require that healthcare outlets take a more 
targeted approach to patient-centered care as an attempt to reduce healthcare use and 
improve patient satisfaction. In this case, HR 1666 should be supported by health care 
professionals, special interests groups, and non-profit organizations as it is a literature 
supported legislative intervention to change the way seriously ill patients are cared for.  
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Strategies for Moving Forward:  
 Adoption of HR 1666 into law would provide legislation that would organize the 
implementation of patient-centered care into existing healthcare delivery systems. The 
HR 1666 bill would provide grants for palliative care education for families and health 
care workers. Increased research of palliative, psychosocial, and symptom management 
strategies would be a bi-product of the passing of this legislation. The benefits provided 
by this bill will impact multiple seriously and chronically ill individuals . Agencies and 
special interest groups who are particularly focused on palliative and patient-centered 
care must support HR 1666 in order to gain public interest. The heart failure community 
will be particularly benefited by this legislation. The American Heart Association has yet 
to formally support this bill. The theology of HR 1666 is in agreement with the scientific 
statements made by the AHA (Allen et al., 2012). Endorsement by the AHA would help 
further public and political interest in this bill. Petitions for AHA support are 
recommended.  
 Supporters of HR 1666 need to capitalize on the current political climate to make 
the case for the legislation. Value-based reimbursement and accountable-care models will 
rely on the best evidence-based practice to reduce healthcare costs and improve patient 
satisfaction. This evidence will continue to point to patient-centered care models which 
include, palliative care, symptom management, and psychosocial support as the most 
appropriate and cost-effective intervention for seriously and chronically ill patients.  
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 Kingdon’ s “political window” of opportunity is close at hand for HR 1666; 
however supporters need to get more public interest for this bill (Kingdon, 2011). 
Unfortunately implementation issues with the Affordable Care Act have taken the 
limelight currently. HR 1666 may have to wait until the quality measures of the ACA 
have had time to be enacted. This will afford supporters of HR 1666 additonal time to 
gain national support and publicity. Healthcare agencies such as university medical 
centers and the Veteran’s Association will certainly be expected to comply with value-
based quality initiatives and should support HR 1666 and promote the passing of the 
legislation. Legislation in HR 1666 will provide necessary services and grant money to 
help organizations be successful at implementing patient-centered care models uniformly. 
Potential Unintended Consequences: 
 A potential unintended consequence of the enactment of HR 1666 is unforeseen 
cost. Several aspects of the bill will require funding such as the stakeholder strategic 
summit, education grants, professional workforce training, quality of life advisory 
committee, and expanded research by the NIH (H.R. 1666, 2013). These aspects of the 
bill may be costly initially but may prove to be cost-effective once appropriate services 
are implemented in established heath care systems. A published cost-benefit analysis 
would be beneficial in gaining support and public acknowledgement of HR 1666.  
 Another potential consequence of this legislation is a significant reduction in 
healthcare usage. While this sounds positive and desirable, low inpatient census and 
fewer ER and outpatient visits could lead to a reduction in revenue for healthcare 
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providers. However, these agencies may recover these costs by developing palliative care 
and symptom management services to offer their patient populations.  
Lastly, insurance coverage of these services may be an issue for some patient 
populations. According to the ACA, increased access to psychosocial and palliative care 
should be covered; however as this remains to be seen in real-time. Issues could arise 
with covered benefits (H.R. 3590, 2011).  
Implementation/Enforcement Issues:  
 Implementation and enforcement of HR 1666 may be difficult if the primary 
stakeholders do not have good buy-in to the legislation. Most importantly, the strategic 
summit hosted by the DHHS would be most beneficial to start implementation of the 
items listed in HR 1666. This summit will help organize efforts and recognize were 
barriers lie among affected organizations and health care outlets.  
 Implementation issues could arise for the CDCP regarding the education grants 
for palliative care for seriously ill patients, families, and health care professions if a good 
strategy is not in place for grant qualification. The CDCP must make clear criteria for 
awarding grant money. Implementation of HR 1666 could become difficult for the HRSA 
regarding the provision of professional workforce training if an organized methodology is 
not systematically used in all healthcare outlets. Also the establishment of a quality of life 
advisory committee to aid the CDCP and HRSA in the dissemination of education and 
implementation will be necessary to avoid implementation and enforcement issues 
regarding HR 1666.  
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 The NIH may face implementation issues regarding the expansion of national 
research programs in the areas of symptom management, palliative, psychosocial and 
survivorships care as there may be low incentive to conduct this research. Once grant 
money is available this may become a more popular area of research.  
Conclusions: 
 The Patient Centered Quality Care for Life Act is a beneficial and necessary piece 
of legislation for patients and families dealing with chronic and serious illness. This 
legislation is also necessary for the healthcare industry as it will ultimately save money 
and promote evidence based practices that have been proven to reduce hospital stay and 
healthcare use. This piece of legislation is particularly necessary for patients with heart 
failure and other “high-dollar” diagnosis as the objectives of the bill will provide better 
symptom management, psychosocial resources, and palliative care for these individuals. 
Organizations such as the American Heart Association should support this bill as it is in 
agreement with the current body of literature produced by the AHA regarding patient-
centered care. Moreover, this legislation will be necessary to support the objectives and 
laws that are provided in the Affordable Care Act and currently of interest in many 
healthcare outlets and organizations.  
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Implementation of a depression screening protocol specific to implantable cardioverter 
defibrillator patients; a quality improvement project 
Abstract 
Background: Depression in patients with implantable cardioverter defibrillators (ICD) is 
a problem that has not been well addressed by providers. In 2012 the American Heart 
Association (AHA) released a scientific statement that recommended structured and 
routine depression screening of these patients. The AHA statement also recommended 
further research on depression screening instruments and their use with this population. 
Aims: 1.) To develop and implement an evidenced based depression screening protocol 
appropriate for patients with an ICD seen in an outpatient setting. 2.) Evaluate provider 
knowledge about depression screening (? Is this what you mean) and depression 
screening practices before and after the depression screening protocol implementation. 3.) 
Determine the efficacy of protocol implementation by evaluating provider screening 
practices and recommendation for treatment.  
Setting: A small cardiology clinic affiliated with the University of Kentucky Cardiology 
Fellowship program.  
Participants: 18 general cardiology fellows who conduct clinic hours on Monday and 
Wednesday afternoons in the specified clinical setting.  
Methods: An evidenced based depression screening protocol was created using the 
Patient Health Questionaire-9 (PHQ-9). Participants were asked to use this screening 
instrument to evaluate all patients with an ICD who were seen in their clinic over a 14-
week period. Participants were to document the screening in the clinic note and bill 
appropriately for the diagnosis of ICD. Participants also were surveyed on their 
knowledge and depression screening practices within this patient population before and 
after implementation of the protocol. A chart review was conducted at the end of the pilot 
study to evaluate provider adherence with the protocol. Process evaluation was conducted 
at the mid and end points of the pilot study. 
Results: The pre and posttest data showed an increase in formal depression screening, use 
of depression screening instruments, and knowledge base after protocol implementation. 
Posttest data showed that 64% of participants reported that they formally screened ICD 
patients compared to only 11% stating they screened pre protocol. Pre test data suggests 
that 89% of participants used a formal instrument 0/10 encounters compared to posttest 
data which suggests that 93% used an instrument at least 1-10/10 encounters. There was 
also a 38% increase in knowledge base about depression in the ICD population post 
protocol implementation. The primary barrier to depression screening identified by 
participants was lack of time. Chart review data was influenced by potential billing 
inconsistencies and poor attendance of ICD patients to the clinic during the pilot period. 
This led to little documented evidence of provider adherence to the protocol in the study 
	  
	  
	  
46	  
	  
	  
	  
setting. Of the charts available for analysis, 50% contained proper execution of the 
depression screening protocol. It is important to note that participating physicians have 
interactions with ICD patients in settings outside the study clinic and may have 
incorporated depression screening practices in other patient encounters. This may explain 
the improved scores of the pre/post test that are not reflected in the chart review data. 
Process evaluation data suggested that participants were equally prepared and satisfied 
with the process at the mid and end points of the pilot study.  
Conclusions: This quality improvement project was successful in creating and 
implementing a depression screening protocol in a small cardiology outpatient clinic. 
There was also marked success in provider knowledge and depression screening practices 
based on the results of pre/post test. In accordance with the scientific statement by the 
AHA, further research is recommended on best practice for depression screening of the 
ICD population.   
 
Introduction 
 The rate of , implantable cardioverter defibrillator (ICD) implantation has 
increased to 250,000 per year in the United States (Dunbar et al., 2012).  Although many 
patients and families with an ICD adjust well psychologically, some patients experience 
anxiety and depressive symptoms in light of life-changing illness and uncertainty 
(Dunbar et al., 2012). Recent research by Suzuki et al. (2010) has determined that 
depression is common and persistent in the ICD population regardless of the medical 
reason for implantation. Suzuki (2010) also found that despite the indication for 
implantation, depression in this population is associated with increased risk for ICD 
shocks. 
The coexistence of depression with chronic illness is associated with increased 
ambulatory care, emergency department visits, days spent in bed due to illness, and 
functional disability (Lichtman, 2009). Medically ill patients with depression have a 
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reduction of adherence to directed therapy, as well as 50%-100% higher medical costs 
than their non-depressed counterparts (Taylor et al., 2008).  Research has shown that a 
reduction in depressive symptoms in HF and medically ill patients improves adherence to 
therapy and decreases medical costs (Taylor et al., 2008; Bauer et al., 2012). Thus, early 
detection of depression in patients with an ICD may prevent a decrease in quality of life, 
and if treated effectively, result in a reduction in health care usage and cost. 
Currently there are no national guidelines for treating depression in patients with an 
implantable cardioverter defibrillator (ICD). The American Heart Association (AHA), 
however, recently endorsed psychosocial recommendations from a scientific statement 
about the psychological response patients and families have to ICD implantation. The 
AHA statement does provide recommendations for practice, which include education and 
depression assessment pre and post implementation (Dunbar et al., 2012). 
There is no specific depression screening method for ICD patients currently used in 
the cardiology clinic of our large, tertiary referral academic medical center. Interviews 
with multiple cardiology providers have verified that in light of the recent AHA 
recommendations, there is a need for a clear depression screening protocol for ICD 
patients in the clinic setting. Current clinic documentation of review of symptoms 
includes a mini depression screening that is often overlooked and “ineffective,” according 
to the co-director of the clinic. Local depression statistics for this population are 
unknown.  However, based on the overwhelming evidence provided in recent literature, it 
is assumed that local depression rates in ICD patients are similar to those found in the 
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literature. Provider knowledge of depression screening may be lacking and there is not an 
appropriate depression-screening instrument used in the clinical practice  
Objectives of this study:  
 1. Create an evidence-based depression screening and treatment protocol specific to 
the ICD population for physician use in the outpatient clinic setting. 
2. Evaluate physician knowledge and depression screening practices before and after 
implementation of a depression screening and treatment protocol.  
3. Determine efficacy of the screening and treatment protocol in promoting physician 
depression screening, and recommendation of treatment when appropriate.  
Guiding question: 
 Will implementation of an evidenced based depression screening protocol specific 
to ICD patients improve provider knowledge and screening behaviors in a small 
cardiology clinic setting?  
Methods 
Study Population: 
 
The study population included cardiology physicians who are currently practicing 
at a local university medical center. There are a total of 18 physicians on this service. The 
investigator recruited these physician participants by providing an educational 
presentation as a guest speaker during a daily cardiology conference. All physician 
participants were asked to be part of the study and were considered a purposive sample. 
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Selection criteria for this study were as follows: Over age 18, current member of the 
group of cardiology physicians, currently conducting cardiology clinic hours on Mondays 
and Wednesdays in the specified clinic, and currently evaluating cardiology patients who 
have ICDs. Consent for participation was obtained during the cardiology conference 
session. This study sample was evaluated as a group and no individual was singled out as 
compliant or non-compliant with study criteria. 
The patients screened by physician participants were also considered participants. 
Evidence of physician adherence with the screening and treatment protocol was obtained 
from the medical record of the patients being screened. The primary investigator had no 
interaction with the screened patients. A waiver of consent for these participants was 
obtained.  
 
Study Design:  
 
  We used a one-group pretest- posttest design. Participating physicians were 
surveyed regarding their current knowledge of depression in ICD patients as well as their 
current use of standardized depression screening instruments. Education regarding the 
population and the protocol implementation was given after collection of the survey. 
Protocol implementation was conducted over a 14-week period following baseline data 
collection. See appendix A: section 2 and 3 for and example of the depression screening 
protocol. We encouraged the consistent use of the screening and treatment protocol by 
participants via regular visits to the cardiology clinic. Physician adherence to the protocol 
was evaluated via a chart review of the electronic medical record at the end of the 
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protocol implementation period. Adherence was determined by evidence of physician 
documentation of screening as well as documentation of recommended treatment and 
follow-up based on depression screening results. A process improvement survey was also 
given midway through the study and again at the end in order to identify opportunities for 
process improvement and for future implementation of the protocol.  
Study Procedures: 
The protocol included the use of the Patient Health Questionnaire – 9 (PHQ-9) for 
screening of patients with ICDs in the Monday/Wednesday cardiology clinic times. This 
screening instrument and recommended treatment follow-up interventions have been 
widely used in the heart failure patient population. The PHQ-9 has been found to have 
good validity and reliability as a screening instrument for depressive symptoms in heart 
failure patients who present with many physical and psychological issues (Kroenke, 
Spitzer, & Williams, 2001; Kroenke & Spitzer, 2002; Lee, Lennie, Heo, & Moser, 2012). 
The screening protocol for this study is consistent with what is recommended by the 
American Heart Association and in the instruction manual for the PHQ-9, which is 
copyrighted by Pfizer (Dunbar, 2012; Patient Health Questionnaire [PHQ] Screeners, 
n.d.). See Appendix A: Section 2 and 3 for the PHQ-9 screening instrument, scoring 
system, and recommendations for follow-up treatment that were used by physicians to 
screen for depression in patients with ICDs. Laminated copies of the PHQ-9 screening 
instruments were given to the participating physicians and were also made available to 
the clinic staff for physician use during clinic times.  The PHQ-9 laminated screening 
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instruments were designed as a guide for multiple uses. No data, markings, or 
information was recorded on the instruments themselves. The participating physicians 
were also given a laminated pocket reference card that contains the recommended 
treatment and follow-up interventions based on the scoring system of the PHQ-9. The 
recommendations are published in association with the instrument and are based on the 
research of the primary developers (Kroenke & Roberts, 2002).  
  The physician’s protocol also included prompts for documentation of the 
depression screening in the medical record at the bottom of the laminated provider 
reference card. A negative screening was to be documented in the medical record as “the 
patient was screened for depression via the PHQ-9 and was not found to have any 
depressive symptoms at this time.” A positive depression screen was to be documented in 
the medical record as “the patient was screened for depression via the PHQ-9 and was 
found to have (mild, moderate, moderately severe or severe) depression with a score 
of....” See Appendix A: Section 3 for sample documentation statements for physician use. 
This provided us with documented evidence of provider adherence at the end of the pilot 
study. 
  The physician participants were given the following resources on the back of their 
protocol reference cards: the phone number to the closest emergency department, local 
psychiatric services, and the Comprehensive Care Center. We also was provided a list of 
Wal-Mart $4 prescriptions as an aid for participating physicians when determining 
medical therapy of select patients.  
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Evaluation methods: 
Evaluation of provider adherence with the screening and treatment protocol was 
conducted by a chart review at the end of the 14-week pilot study. This was performed 
via use of the electronic medical record. The patients were identified by a list generated 
by the cardiology billing coder. This list included patients who have a documented 
Implantable Cardioverter Defibrillator (ICD-9 billing code V45.02) and who were seen in 
the clinic during the time period of the study. This list contained the medical record 
numbers of applicable patients. This list was kept confidential. Patients were de-
identified by numbering system (pt.#1, 2, 3…) for data analysis purposes. The data 
extracted from the medical record included: physician documentation of depression 
screening, depression screening score, and physician documentation of appropriate 
treatment or follow up based on the protocol. These treatments or follow-up included: 
recommended follow-up depression screening, recommendation for counseling, 
pharmacotherapy, psychotherapy, and expedited mental health referral. Please see 
Appendix A: Section 4 for an example of the data collection instrument used for 
verifying provider adherence. 
An anonymous pre/post test survey was created and given prior to protocol 
implementation and administered to the participating physicians at the end of the pilot 
study. This survey assessed physician knowledge of depression in the ICD population as 
well as current screening practices before and after participation in the protocol. The 
survey was collected anonymously. No names of participating physicians were associated 
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with any specific surveys and results were evaluated as a group versus individual 
analysis. See appendix A: section 1 for an example of the pre/post survey given to 
participating physicians.  
A process evaluation survey about the use of the screening protocol and the ease 
of use for physicians in the clinical setting was given to participating physicians midway 
through the pilot study and as well as at the end. This evaluation is provided in the Tool 
Kit for Promoting Evidence-Based Practice (Titler, 2002). This process evaluation will 
help guide future implementation of the protocol. See appendix A: section 5 for an 
example of the process evaluation survey.  
Analysis: 
 Data was analyzed using IBM SPSS software version 21 (IBM SPSS, Armonk, 
NY). Frequency data was collected to evaluate the impact of the intervention on 
participating providers scores on the 11-item pre/post test survey of knowledge of 
depression in ICDs and current practices. See Appendix A: section 1 for an example of 
the survey. Items from the pre/post test that involved knowledge of depression in the ICD 
population, current depression screening practices, and perceived barriers to systematic 
depression screening were analyzed by percentages pre and post intervention.  
 Frequency data was used to evaluate the level of adherence to the depressions 
screening protocol based on the following categories: documentation of screening, 
screening score, follow-up depression screening recommended, recommendation for 
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counseling, pharmacotherapy prescribed, psychotherapy referral, and expedited referral 
to mental health specialist. See Appendix A: section 4 for data collection categories.  
 The results of the process evaluation monitor are analyzed by mean score of both 
the midpoint and endpoint surveys. Results of this survey provided information on how 
the participants perceived the implementation process.  
Results 
 This quality improvement project took place in a small cardiology clinic setting. 
The participants of the study included 18 physicians who conducted a general cardiology 
clinic on Mondays and Wednesdays from 1pm-5pm. The physicians rotated turns in the 
clinic with 3-4 participants in the clinic during specified clinic times. A member of the 
cardiology faculty at the local university oversaw physician participants during clinic 
times. This faculty member was not a participant in the study but provided support to the 
primary investigator and participants during the pilot period. Support from the cardiology 
department was maintained throughout the pilot study. 
 This process improvement study was guided by the Toolkit for Promoting 
Evidence-Based Practice (Titler, 2002). The following diagram shows the progression of 
the intervention.  
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 Support for this implementation was consistent throughout the pilot phase. 
Physician participants continually provided positive feedback and expressed ongoing 
adherence to the protocol. However, throughout the implementation it became clear that 
physician participants were not able to use the screening protocol as often as had been 
expected due to low volume of ICD patients being seen in the clinic. This was reported to 
us as “abnormal” by the clinic staff and participating physicians. A study extension was 
obtained in order to compensate for the low volume of ICD patients being seen. Despite 
low number of opportunities to use the screening protocol, participants remained 
committed to the process and when asked, produced their laminated protocol cards during 
random visits to the clinic setting. 
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The pre/post test survey results:  
(Table 1) 
Pre/post test survey 
result by 
Individual question: 
Pre-test responses: (n=18) Post-test responses: (n=14) 
 Agreed Neutral or 
Disagreed 
Agreed Neutral or  
Disagreed 
Untreated depression is a 
problem in ICD patient 
population. 
16.67 strongly 
agree, 44.44% 
agree  
33.33% neither 
agree/disagree, 
5.56% disagree 
42.86% 
strongly 
agreed, 42.86% 
agreed 
14.29% neither 
agree/disagree 
Untreated depression negatively 
impacts overall health. 
33.33% 
strongly agree, 
55.56% agree 
11.11% neither 
agree/disagree 
50% strongly 
agree, 50% 
agree 
 
Untreated depression negatively 
impact medical compliance. 
22.22% 
strongly agree, 
62.11% agree 
16.67 neither 
agree/disagree 
42.86% 
strongly agree, 
57.14% agree 
 
After assessing an ICD patient, 
can you tell if they are 
depressed?  
94.44% 
sometimes 
5.56% no never 14.29% 
always, 
85.71% 
sometimes 
 
To determine depression in the ICD patient, participants use: 
Sad Face/Demeanor 83.33% agreed 16.67% 
disagreed 
71.43% agreed 28.57% 
disagreed 
Negative comments made by 
patient to determine depression. 
71.22% agreed 27.78% 
disagreed 
85.71% agreed 14.29% 
disagreed 
Report from spouse/caretaker to 
determine depression. 
83.33% agreed 16.67% 
disagreed 
85.71% agreed 14.29% 
disagreed 
Other indicator 5.56% agreed 94.44% 
disagreed 
14.29% agreed 85.71% 
disagreed 
Out of 10 ICD patient 
encounters, how many times do 
you formally screen for 
depression using a standardized 
instrument?  
88.89% - 0/10 
5.56% - 1/10 
5.56% - 8/10 
 
 
7.14% - 0/10 
14.29% - 1/10 
7.14% - 2/10 
21.43% - 5/10 
14.29% - 7/10 
14.29% 8/10 
21.43% 10/10 
When formally screening patients for depression participants use: 
PHQ-9 5.56% agreed 94.44% 
disagreed 
64.29% agreed 35.71% 
disagreed 
Beck  0% agreed 14.29% agreed 85.71% 
disagreed 
HADS-A/D 0% agreed 7.14% agreed 92.86% 
disagreed 
Other standardized instrument 5.56% agreed 94.44% 
disagreed 
7.14% agreed 92.86% 
disagreed 
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Do not use a formal screening 
instrument 
88.9% agreed 11.11% 
disagreed 
35.71% agreed 64.29% 
disagreed 
Participants manage depression in ICD by: 
 “wait and see” approach 5.56% agreed 0% agreed 
Manage personally with 
medication 
44.44% agreed 57.14% agreed 
Refer for management  50% agreed 42.86% agreed 
If a simple depression screening 
protocol were readily available, 
would you be more likely to 
diagnose/manage? 
88.24% agreed 11.76% 
disagreed 
92.86% agreed 7.14% 
disagreed 
Knowledge base: 
Up to 46% of ICD recipients 
report depression (true) 
100% agreed 100% agreed 
Negative psychosocial response 
to ICD therapy is NOT 
associated with poor outcomes. 
(False) 
100% disagreed 100% disagreed 
Patients who have and ICD for 
primary prevention have a 
greater understanding of their 
disease and prognosis than 
patients who have received an 
ICD due to cardiac arrest or 
sustained arrhythmia. (False) 
100% disagreed 14.29% agreed 85.71% 
disagreed 
Up to 45% of ICD patient with 
emotional distress do not 
receive treatment. (True) 
94.44% agreed 5.56% disagreed 100% agreed 
AHA recommends use of an 
organized screening instrument 
to evaluate ICD patients for 
emotional distress. (True) 
88.24% agreed 11.76% 
disagreed 
100% agreed 
Depression screening during 
office visits benefits ICD 
patients. (True) 
100% agreed 100% agreed 
Barriers identified by providers 
regarding properly screening 
ICD patients for depression. 
Lack of access to screening 
instruments, lack of time, do not 
keep up with depression 
guidelines, prefer not to manage 
depression, lack of ability to 
monitor treatment and 
improvement in symptoms 
Time constraints, lack of time, 
lack of time and too many things 
to remember, time constraints and 
out of scope of practice 
 
 There were a total of 18 participants who completed the pretest survey and only 
14 who completed the posttest. The 4 study participants who did not complete the 
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posttest were no different demographically from the study sample; however, they were 
unable to be contacted for post testing. The results of the pre and post survey show an 
increase of knowledge and screening practices by the study participants after the protocol 
implementation. The posttest results show that there was an over all increase in formal 
screening by participants. At the time of the pre test, only 11% said they formally 
screened patients compared to 64% posttest. The posttest results showed that 93% of 
participants used a formal depression screening instrument at least 1-10/10 encounters as 
compared to 89% who stated they used a formal instrument 0/10 at the time of the 
pretest. Pre and posttest results both show that participants are willing to diagnose and 
manage depression in this population if a simple depression screening protocol were 
readily available (88% agreed pre/ 93% agreed post). Pretest data revealed that 41% of 
participant answered the knowledge base series of questions correctly prior to protocol 
implementation as compared to 57% who answered correctly post implementation. 
According the pre/post data over all knowledge and screening practices improved by the 
end of the pilot study.  
Retrospective chart review results: 
 To determine adherence to the depression screening protocol, a chart review was 
conducted. Charts of ICD patients seen in this cardiology clinic during the 14-week pilot 
study were audited by billing code for ICD to determine the efficacy of the protocol 
implementation. See Appendix A: Section 4 for an example of the adherence data 
collection form. Only 4 charts were found to contain the billing code for ICD during the 
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14-week pilot period. This was significantly less than expected based on reports by the 
participants. This low number of charts audited may have been a result of few ICD 
patient encounters as well as improperly billed clinic visits. Of the 4 charts audited, 2 
contained documentation of screening. This documentation also contained course of 
action by provider, which was in adherence to the screening instrument. See table 2 for 
data collection. According to the data collected there was a 50% adherence rate with the 
protocol, however, the accuracy of the billing process remains questionable. Since the 
protocol relied upon use of the appropriate billing code for ICD to capture patients who 
were eligible for screening by participants, it is impossible to determine the efficacy of 
the screening protocol in regards to participant adherence.  
Chart review Results: 
(Table 2) 
Patient  
Number 
(1,2,3…) 
Doc. Of  
Screening 
(1-yes, 2-
No) 
Screening 
Score 
From Doc. 
(actual 
score) 
Follow up 
depression 
screening 
recommended by 
provider 
(1-yes, 2-No) 
Recs. for 
counseling by 
provider 
(1-yes, 2-no) 
RX 
prescribed 
By provider 
(1-yes, 2-No) 
Psych. 
Therapy 
Referral 
(1-yes, 2-
no) 
Expedited  
Referral to 
mental health 
(1-yes, 2-no) 
Right 
treatment 
Based on 
PHQ-9 score 
(1-yes, 2-no) 
1 2        
2 2        
3 1 0 2 2 2 2 2 1 
4 1 11 2 2 1 2 2 1 
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Process evaluation results: 
 A process evaluation, adapted from the IOWA model of evidence based practice 
implementation, was used to evaluate the preparation and satisfaction of participants 
(Titler, 2002). This evaluation was given to the study sample mid-way through the pilot 
period and again at the end. See Appendix A. Section 5 for an example of the survey. 
Based on a likert scale, a score was given to each survey, which ranged from 9-36. The 
higher the score, the more prepared and satisfied the participants were with the process. A 
total of 10 participants completed the process evaluation at the mid-point with a mean 
score of 30.7. A total of 13 participants completed the process evaluation at the end-point 
with a mean score of 29.8. Participants clearly had the same perceptions of preparedness 
and satisfaction with the process at the mid and end point of the pilot period.   
Discussion 
 In accordance with the AHA scientific statement released in 2012, this quality 
improvement project attempted to implement a structured depression screening protocol 
specific to the ICD patient. The AHA scientific statement does not specify which 
screening instrument is optimal for this population, however, further research was 
recommended (Dunbar et al., 2012). The PHQ-9 was determined to be a reasonable 
choice for this population based on extrapolation from literature regarding depression in 
the heart failure population. Implementation of the protocol was widely supported by the 
division of cardiology at a local university and satellite clinic. Initial participation was 
100% by all 18 cardiologist selected for this study. Although willing, participants were 
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unfortunately afforded few opportunities to enforce the protocol due to lack of ICD 
patients being seen in the clinic during the pilot period. In addition, proper billing code 
use is also questionable based on the unexpectedly few charts available for audit after the 
14-week pilot study. Posttest participation included only 14 of the original participants. It 
is unclear why 4 participants failed to complete the study; however, vacations and other 
obligations may have played a role. Despite these challenges, pre and posttest data 
suggests that there was an improvement in participant knowledge and screening practices 
within this patient population. It is important to note that participating physicians have 
duties outside of this clinic setting and potentially have incorporated screening practices 
from this protocol in other patient encounters. This would explain why pre/post data 
suggests high adherence to the protocol.  
Limitations: 
 The limitations of this study include small sample of participating physicians. 
This quality improvement project was created to be a small pilot study conducted by only 
one primary investigator, however, implementation results may be different if conducted 
with a larger group of providers. Length of pilot period was also a limitation.  
Implementation of this protocol over a longer length of time may have improved 
adherence and attitudes among the culture of the clinic. Opportunities for participants to 
use the protocol were few. Unfortunately the cardiology clinic saw an unusually low 
number of patients with ICDs during the pilot phase. The protocol usage and adherence 
may have been more successful if conducted in a cardiology clinic dedicated to heart 
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failure or electro-physiology. Reliance on proper billing coding for capturing adherence 
data collection proved to be a strong limitation of this study. Perhaps incorporating other 
billing codes into the protocol may improve data collection. Also, introducing billing 
prompts for providers in the electronic medical record may also be helpful for future 
implementation of the protocol. Moreover, implementation of this protocol may be better 
suited for settings in which ICD patients are seen regularly.  
Conclusions: 
 This quality improvement project attempted to provide evidence to support the 
AHA scientific statement released in 2012 (Dunbar et al.). In doing so, a standardized 
depression screening protocol using the PHQ-9 was implemented in a small cardiology 
clinic setting. Despite few opportunities to use the screening instrument, the objectives of 
this quality improvement project were met. An evidence-based protocol was created and 
implemented. Knowledge and screening practices of participants were evaluated pre and 
post implementation, and efficacy of the implementation was evaluated. Knowledge and 
screening practices of participants improved based on the pre/post test after the protocol 
implementation; however, it is unclear if the protocol implementation was effective in the 
clinic setting due to low number of ICD patients seen in clinic as well as possible 
inaccurate billing. Again, it is important to note that participating physicians may have 
incorporated the protocol into practice outside of the study clinic setting, and thus shown 
and improvement in knowledge and practice on the pre/post test that was not able to be 
verified via the chart review methods of this study. Perceived barriers to implementation 
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of screening practices by participants included lack of time and ability to monitor patient 
outcomes. Further research on ways of improving these barriers may be beneficial. This 
protocol may serve as a model for future depression screening implementation in multi-
disciplinary setting. 
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In conclusion I would like to once again emphasize the importance of addressing 
depression in the heart failure and ICD population. Manuscript one focused on the body 
of knowledge regarding depression screening instruments used in heart failure patients. 
From this review, an evidence based depression screening protocol was created for use in 
the ICD population. Manuscript two reviewed current legislation that may improve the 
quality of life for patients with heart failure and other chronic illnesses. Manuscript three 
evaluated the evidenced based depression screening protocol implementation in a UKMC 
cardiology clinic. More research is necessary to determine the best method of changing 
practice and improving outcomes for heart failure and ICD patient populations. 
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Appendix A: 
1. Pre/Post Test 
2. Screening instrument for use by providers 
3. Recommended treatment/follow-up and documentation statements 
4. Process evaluation instrument 
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1. Pre/Post Test: 
 
 
To start a few questions about you and your practice. 
 
1. What is your current position?  Circle one. 
 
1. UK Gill Heart Cardiology Fellow 2. Other (specify) _______________ 
 
 
2. How strongly do you agree or disagree with each 
of the following: Strongly agree Agree 
Neither 
agree nor 
disagree 
Disagree Strongly 
disagree 
 Untreated depression:      
       
a. Is a problem in the ICD patient population? 1 2 3 4 5 
b. Negatively impacts the overall health of individual 
ICD patients? 1 2 3 4 5 
c. Negatively impacts medical compliance of 
individual patients? 1 2 3 4 5 
 
 
3. After you are done assessing an ICD patient, can you tell if they are depressed? 
 
1. Yes, always 2. Sometimes 3. No, never 
 
 
4. Which of the following indicators do you use to determine if an ICD patient is depressed?  Circle all 
that apply. 
 
a. Sad face and demeanor d. None of these 
b. Negative comments e. Other (specify) ___________________________ 
c. Report from spouse or caretaker   
 
5. Out of every 10 times you see an individual ICD patient,  how many times do you formally screen 
(using a standardized instrument) for depression?  If every time/visit with a patient, enter 10, if never, 
enter 0.   
 
 
/__/___/ Times out of 10 visits formally screen for depression 
 
 
6. Which of the following standardized instruments do you use?  If never formally screen, circle item 
“e”. 
a. PHQ-9 d. Other (specify) _____________________________________ 
b. Beck e. Don’t use formal screening instrument 
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c. HADS-A/D   
7. How do you manage depression in your ICD patients?   Circle one. 
 
1. Use a “wait and see” approach 3. Refer for management 
2. Manage it myself with medications 4. Other (specify) _________________ 
 
8. If a simple depression screening protocol were readily available to you, would you be more likely to 
diagnose and manage depression in your ICD patients? 
 
0. No 1. Yes 
 
9. In general, what percentage of ICD recipients have anxiety?  Your best guess is fine.  Circle one. 
 
1. 5% 3. 40% 5. Other (specify) _____________% 
2. 20% 4. 85%   
 
 
10. Please indicate whether the following statements are true or false.  Your best guess 
is fine. 
  
  True False 
a. Up to 46% of ICD recipients report depression 1 0 
b. Negative psychological response to ICD therapy is NOT associated with life-
threatening outcomes 1 0 
    
c. Patients who have received an ICD for primary prevention have a great 
understanding of their disease and prognosis than patients who have received an 
ICD due to cardiac arrest or sustained arrhythmia 
1 0 
    
d. Up to 45% of ICD patients with emotional distress receive no treatment 1 0 
e. The AHA recommends that providers (Electro physiologists, Cardiologists, 
Nurses, and Primary Care Providers) use an organized screening instrument to 
evaluate ICD patients during follow-up for evidence of emotional stress 
1 0 
    
f. Screening for depression during office visits can benefit the ICD patient 1 0 
 
 
11. Please use the space below to enter any barriers you face in your practice when deciding whether or 
not to screen ICD patients for depression.  For example, lack of time, lack of access to screening 
instruments, your patients don’t require screening, etc. 
 
 
 
 
 
	  
	  
	  
72	  
	  
	  
	  
2. PHQ-9 Assessment Instrument:  
FOR PHYSICIAN USE: 
Step 1: Does the patient have an Implantable Cardioverter Defibrillator? Yes – continue 
questionnaire, No- STOP NOW. 
Step 2:  PHQ-9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over the last 2 weeks, how often have you been bothered by any of the following problems?  
 Not at all Several 
days 
More than half 
the days 
Nearly every 
day 
Little interest in or pleasure in doing things 0 1 2 3 
Feeling down, depressed, or hopeless 0 1 2 3 
Trouble falling or staying asleep, or sleeping too much 0 1 2 3 
Feeling tired or having little energy 0 1 2 3 
Poor appetite or overeating 0 1 2 3 
Feeling bad about yourself – or that you are a failure or 
have let yourself or family down 
0 1 2 3 
Trouble concentrating on things, such as reading the 
newspaper or watching television 
0 1 2 3 
Moving or speaking so slowly that other people could 
have noticed. Or the opposite – being so fidgety or 
restless that you have been moving around a lot more 
than usual 
0 1 2 3 
Thoughts that you would be better off dead, or of 
hurting yourself 
0 1 2 3 
Add up columns:     
Total Score:    
*If you checked off any problems, how difficult have these problems made it for you to do your work, take 
care of things at home, or get along with other people?  
Not difficult at all ___ 
Somewhat difficult ___ 
Very difficult ___ 
Extremely Difficult___ 
PHQ9 Copyright © Pfizer Inc. All rights reserved. Reproduced with permission of Pfizer, Inc. 
PRIME-MD ® is a trademark of Pfizer Inc. 
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3. Recommended treatment/follow-up and documentation statements: 
 
Interpretation of Total Score: 
• Add up totals from each column of the instrument and combine together for 
a total score 
• Shaded areas are considered positive symptoms. Refer to PI for PHQ-9 
Manual  
PHQ-9 Scores and Proposed 
Treatment Actions * PHQ-9 
Score  
Depression Severity  Proposed Treatment Actions  
0 – 4  None-minimal  None  
5 – 9  Mild  Watchful waiting; repeat PHQ-9 
at follow-up  
10 – 14  Moderate  Treatment plan, considering 
counseling, follow-up and/or 
pharmacotherapy  
15 – 19  Moderately Severe  Active treatment with 
pharmacotherapy and/or 
psychotherapy  
20 – 27  Severe  Immediate initiation of 
pharmacotherapy and, if severe 
impairment or poor response to 
therapy, expedited referral to a 
mental health specialist for 
psychotherapy and/or 
collaborative management  
(Kroenke, 2002) 
 
PLEASE DOCUMENT THE FOLLOWING STATEMENTS IN THE CLINIC 
NOTE: 
 
POSITIVE SCREEN: “The patient was screened for depression via the PHQ-9 and 
was found to have (mild, moderate, moderately severe or severe) depression with a score 
of...” 
NEGATIVE SCREEN: “The patient was screened for depression via the PHQ-9 and 
was not found to have any depressive symptoms at this time.” 
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5. Process evaluation instrument: 
 
Process Evaluation Monitor 
- Adapted	  from	  the	  Toolkit	  for	  Promoting	  Evidence-­‐Based	  Practice	  
 
 
Directions: Please circle the number that best communicates your perception about your 
use of the Depression Screening Protocol for ICD Patients. 
 
 Strongly  
Disagree 
Disagree Agree Strongly 
Agree 
1. I feel knowledgeable to carry out the 
depression screening protocol.  
1 
 
2 
 
3 
 
4 
 
2. Implementing the depression screening 
protocol enhances job satisfaction of the 
fellowship. 
1 2 3 4 
3. I feel supported in my efforts to implement 
the depression screening protocol.  
1 2 3 4 
4. I feel well prepared to carry out the 
depression screening protocol with the 
assistance from others. 
1 2 3 4 
5. I am able to identify factors that relate to 
depression in the ICD population. 
1 2 3 4 
6. I am able to identify and carry out the 
essential activities of the depression screening 
protocol and recommended interventions. 
1 2 3 4 
7. I had enough time to learn about the 
depression screening protocol before it was 
implemented. 
1 2 3 4 
8. We are managing depression in the ICD 
population better with the use of the protocol.  
1 2 3 4 
9. The protocol enables me to meet 
psychosocial needs of most ICD recipients.  
1 2 3 4 
 
 
 
Titler, M. G. (2002). Toolkit for Promoting Evidence-Based Practice. Iowa City, IA: The 
University of Iowa Hospitals and Clinics, Department of Nursing Services and 
Patient Care. 
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